DRKS00024682已完成不适用
A retrospective multi-centre analysis investigating the effects of the rate of change in glucose on intermittently scanned continuous glucose monitoring (isCGM) system accuracy in people with type 1 diabetes - ROCI 1
niversität BayreuthInstitut für SportwissenschaftenDivision of Exercise Physiology and Metabolism0 个研究点目标入组 311 人开始时间: 2021年8月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 311
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Participants being clinically diagnosed with type 1 diabetes
- •Using an isCGM system against reference blood glucose measurement
- •Timepoints of measurements noted to assess the rate of change
排除标准
- •Any data that is missing in the inclusion criteria
研究者
相似试验
招募中
4 期
A study to understand T2D patient characteristics with respect to medicines and clinical featuresCTRI/2022/10/046335ovo Nordisk Pharma Gulf FZE
已完成
不适用
A multi-center retrospective observational study in patients with relapsed and refractory multiple myeloma receiving once-weekly carfilzomib dosing in combination with dexamethasone in a real-world setting in Japan (Weekly-CAR study)Multiple myelomaJPRN-UMIN000043049Ono Pharmaceutical Co., Ltd.150
已完成
不适用
A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancerPatients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.JPRN-UMIN000046824niversity of Toyama400
已完成
不适用
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancerJPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850
招募中
Unknown
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206